These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1649289)

  • 1. Enhanced repair and regeneration of periodontal lesions in tetracycline-treated patients. Case reports.
    Moskow BS; Tannenbaum P
    J Periodontol; 1991 May; 62(5):341-50. PubMed ID: 1649289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetracyclines inhibit tissue collagenases. Effects of ingested low-dose and local delivery systems.
    Golub LM; Goodson JM; Lee HM; Vidal AM; McNamara TF; Ramamurthy NS
    J Periodontol; 1985 Nov; 56(11 Suppl):93-7. PubMed ID: 3001266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing, and of adjunctive tetracycline therapy.
    Slots J; Mashimo P; Levine MJ; Genco RJ
    J Periodontol; 1979 Oct; 50(10):495-509. PubMed ID: 385821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article.
    Ingman T; Sorsa T; Suomalainen K; Halinen S; Lindy O; Lauhio A; Saari H; Konttinen YT; Golub LM
    J Periodontol; 1993 Feb; 64(2):82-8. PubMed ID: 8433257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repair of an extensive periodontal defect after tetracycline administration. A case report.
    Moskow BS
    J Periodontol; 1986 Jan; 57(1):29-34. PubMed ID: 3456037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host modulation with tetracyclines and their chemically modified analogues.
    Golub LM; Suomalainen K; Sorsa T
    Curr Opin Dent; 1992 Mar; 2():80-90. PubMed ID: 1325849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tetracycline resistance in oral microorganisms in patients with periodontal disease].
    Olsvik B
    Nor Tannlaegeforen Tid; 1991 Jan; 101(2):50-2. PubMed ID: 1861963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug.
    Lee HM; Ciancio SG; Tüter G; Ryan ME; Komaroff E; Golub LM
    J Periodontol; 2004 Mar; 75(3):453-63. PubMed ID: 15088884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of the effect of tetracycline root preparation on guided tissue regeneration in the treatment of Class II furcation defects.
    Parashis AO; Mitsis FJ
    J Periodontol; 1993 Feb; 64(2):133-6. PubMed ID: 8433253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic management of periodontal diseases using systemically administered agents.
    Mariotti A; Monroe PJ
    Dent Clin North Am; 1998 Apr; 42(2):245-62. PubMed ID: 9597336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetracycline inhibition identifies the cellular sources of collagenase in gingival crevicular fluid in different forms of periodontal diseases.
    Suomalainen K; Halinen S; Ingman T; Lindy O; Saari H; Konttinen YT; Golub LM; Sorsa T
    Drugs Exp Clin Res; 1992; 18(3):99-104. PubMed ID: 1425210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetracycline fibres used to control bacterial infection during guided tissue regeneration (GTR).
    Sbordone L; Barone A; Di Genio M; Ramaglia L
    Minerva Stomatol; 2000; 49(1-2):27-34. PubMed ID: 10932905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiological response of localized sites with recurrent periodontitis in maintenance patients treated with tetracycline fibers.
    Wong MY; Lu CL; Liu CM; Hou LT
    J Periodontol; 1999 Aug; 70(8):861-8. PubMed ID: 10476893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetracycline-coated polytetrafluoroethylene barrier membranes in the treatment of intraosseous periodontal lesions.
    Zarkesh N; Nowzari H; Morrison JL; Slots J
    J Periodontol; 1999 Sep; 70(9):1008-16. PubMed ID: 10505803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of collagen I and XII mRNAs in Porphyromonas gingivalis-induced periodontitis in rats: the effect of doxycycline and chemically modified tetracycline.
    Karimbux NY; Ramamurthy NS; Golub LM; Nishimura I
    J Periodontol; 1998 Jan; 69(1):34-40. PubMed ID: 9527559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity.
    Golub LM; McNamara TF; D'Angelo G; Greenwald RA; Ramamurthy NS
    J Dent Res; 1987 Aug; 66(8):1310-4. PubMed ID: 3040832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nonantimicrobial properties of tetracycline for the treatment of periodontal disease.
    Vernillo AT; Ramamurthy NS; Golub LM; Rifkin BR
    Curr Opin Periodontol; 1994; ():111-8. PubMed ID: 8032451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating periodontal diseases with tetracycline-impregnated fibers: data and controversies.
    Greenstein G
    Compend Contin Educ Dent; 1995 May; 16(5):448-55; quiz 456. PubMed ID: 8624985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tetracycline-containing gel and a mixture of tetracycline and citric acid-containing gel on non-surgical periodontal therapy.
    Jeong SN; Han SB; Lee SW; Magnusson I
    J Periodontol; 1994 Sep; 65(9):840-7. PubMed ID: 7990020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guided tissue regeneration with dentin biomodification.
    Dyer BL; Caffesse RG; Nasjleti CE; Morrison EC
    J Periodontol; 1993 Nov; 64(11):1052-60. PubMed ID: 8295090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.